Betty Willems
- Virology top 1%
- HIV Research and Treatment 36
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 18
- HIV/AIDS Research and Interventions 12
-
- Immune Cell Function and Interaction 10
- Immunotherapy and Immune Responses 4
- Hepatology top 10%
- Hepatitis C virus research 3
-
- Herpesvirus Infections and Treatments 6
- Cytomegalovirus and herpesvirus research 4
- Co-authors
- Guido van der GroenWouter JanssensLeo HeyndríckxKatrien FransenKatleen VereeckenJohn N. NkengasongL HeyndrickxDavid A. Davis
- Journals
- Journal of Medical Virology (10 papers)AIDS Research and Human Retroviruses (7 papers)AIDS (6 papers)
- Partner nations
- BelgiumPhilippinesSlovakia
In The Last Decade
Betty Willems
39 papers receiving 755 citations
Peers
Comparison fields: 5 of 48
- Virology 660
- Infectious Diseases 494
- Immunology 210
- Hepatology 60
- Epidemiology 160
Countries citing papers authored by Betty Willems
This map shows the geographic impact of Betty Willems's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Betty Willems with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Betty Willems more than expected).
Fields of papers citing papers by Betty Willems
This network shows the impact of papers produced by Betty Willems. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Betty Willems. The network helps show where Betty Willems may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Betty Willems, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 35 | |
| 2 | 2011 | 7 | |
| 3 | 2010 | 16 | |
| 4 | 2009 | 7 | |
| 5 | 2003 | 10 | |
| 6 | 2003 | 5 | |
| 7 | 2002 | 8 | |
| 8 | 1999 | 5 | |
| 9 | 1998 | 24 | |
| 10 | 1998 | 23 | |
| 11 | 1998 | 46 | |
| 12 | 1997 | 16 | |
| 13 | 1996 | 10 | |
| 14 | 1995 | 18 | |
| 15 | 1995 | 5 | |
| 16 | 1995 | 37 | |
| 17 | 1995 | 14 | |
| 18 | 1994 | 15 | |
| 19 | 1994 | 11 | |
| 20 | 1994 | 14 |
About Betty Willems
Betty Willems is a scholar working on Virology, Infectious Diseases and Immunology, having authored 39 papers that have together received 776 indexed citations. Recurring topics across this work include HIV Research and Treatment (36 papers), HIV/AIDS drug development and treatment (18 papers), HIV/AIDS Research and Interventions (12 papers), Immune Cell Function and Interaction (10 papers), Herpesvirus Infections and Treatments (6 papers), Immunotherapy and Immune Responses (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Virology (660 citations), Infectious Diseases (494 citations) and Immunology (210 citations). Betty Willems has collaborated with scholars based in Belgium, Philippines and Slovakia. Frequent co-authors include Guido van der Groen, Wouter Janssens, Leo Heyndríckx, Katrien Fransen, Katleen Vereecken, John N. Nkengasong, L Heyndrickx, David A. Davis, Marleen Vanden Haesevelde and Eric Saman. Their work appears in journals such as Journal of Medical Virology, AIDS Research and Human Retroviruses, AIDS, Vaccine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.